Exploring the role and clinical implications of proteasome inhibition in medulloblastoma.

Pediatric Blood & Cancer
Clay M HoerigDaniela A Bota

Abstract

Ubiquitin proteasome-mediated protein degradation has been implicated in posttranslational oncogenesis in medulloblastoma. Current research is evaluating the clinical implications of proteasome inhibition as a therapeutic target. In medulloblastoma cell lines, proteasome inhibitors induce apoptosis and inhibit cell proliferation via multiple pathways involving activation of caspase pathways, NFκB (nuclear factor kappa-light-chain-enhancer of activated B cells) pathway inhibition, reduced AKT/mTOR pathway activity, and pro-apoptotic protein expression. Second-generation proteasome inhibitors demonstrate blood-brain barrier penetration while maintaining antitumor effect. This review summarizes the ubiquitin-proteasome system in the pathogenesis of medulloblastoma and the potential clinical implications.

References

Oct 1, 1990·Genomics·P H CogenM S Edwards
Jan 19, 1999·Annual Review of Cell and Developmental Biology·A Wodarz, R Nusse
Apr 15, 2000·Developmental Dynamics : an Official Publication of the American Association of Anatomists·J K LeeH Suh-Kim
Jul 4, 2001·Nature Reviews. Neuroscience·V Y Wang, H Y Zoghbi
Mar 28, 2002·Physiological Reviews·Michael H Glickman, Aaron Ciechanover
Jan 7, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Chris EnglundRobert F Hevner
Mar 17, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Andrew J FinkRobert F Hevner
Mar 29, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Margaret C ThompsonRichard J Gilbertson
Oct 4, 2007·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Barbara Carletti, Ferdinando Rossi
Jul 15, 2009·Acta Neuropathologica·Norman L Lehman
Mar 10, 2010·Journal of Neuro-oncology·Surasak PhuphanichJeffrey J Olson
Dec 15, 2010·Nature·Paul GibsonRichard J Gilbertson
Feb 11, 2011·Developmental Neurobiology·Masahiko Hibi, Takashi Shimizu
Jun 3, 2011·Journal of Neuro-oncology·Sachiko Ohshima-HosoyamaCharles Keller
Jul 8, 2011·Stem Cells and Development·Parthiv HaldipurShyamala Mani
Oct 19, 2011·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Zhiwei WangWenyi Wei
Dec 3, 2011·Acta Neuropathologica·Michael D TaylorStefan M Pfister
Sep 12, 2014·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Joanna YeungDan Goldowitz
Oct 7, 2015·The Cerebellum·Ketty LetoRichard Hawkes
Oct 27, 2015·Cellular and Molecular Life Sciences : CMLS·Annarita De LucaKetty Leto
May 31, 2016·Neurologia Medico-chirurgica·Noriyuki Kijima, Yonehiro Kanemura
Dec 3, 2016·Therapeutic Advances in Hematology·B FrankenH M Lokhorst
Apr 15, 2017·Journal of Neurosurgery·Weijun WangThomas C Chen
Jun 14, 2017·Cancer Cell·Florence M G CavalliMichael D Taylor
Apr 15, 2018·Translational Research : the Journal of Laboratory and Clinical Medicine·Ji Eun ParkKyung Bo Kim
Jun 1, 2018·Journal of Oncology·Gergely VargaTamás Masszi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Related Papers

Vojnosanitetski pregled. Military-medical and pharmaceutical review
B DRAGOJEVICM BUCIC
Clinical Neurosurgery
J T Rutka
Archives of Disease in Childhood
C C Bailey
Neuro-Chirurgie
M ChouxE Tapounie
Nederlands tijdschrift voor geneeskunde
J A VAN HASSELT
© 2021 Meta ULC. All rights reserved